Pandey Kailash N, Nguyen Huong T, Sharma Guru Dutt, Shi Shang-Jin, Kriegel Alison M
Department of Physiology, Tulane University School of Medicine and Health Sciences Center, New Orleans, Louisiana 70112, USA.
J Biol Chem. 2002 Feb 15;277(7):4618-27. doi: 10.1074/jbc.M106436200. Epub 2001 Nov 9.
We examined the kinetics of internalization, trafficking, and down-regulation of recombinant guanylyl cyclase/natriuretic peptide receptor-A (NPRA) utilizing stably transfected 293 cells expressing a very high density of receptors. After atrial natriuretic peptide (ANP) binding to NPRA, ligand-receptor complexes are internalized, processed intracellularly, and sequestered into subcellular compartments, which provided an approach to examining directly the dynamics of metabolic turnover of NPRA in intact cells. The translocation of ligand-receptor complexes from cell surface to intracellular compartments seems to be linked to ANP-dependent down-regulation of NPRA. Using tryptic proteolysis of cell surface receptors, it was found that approximately 40-50% of internalized ligand-receptor complexes recycled back to the plasma membrane with an apparent t(12) = 8 min. The recycling of NPRA was blocked by the lysosomotropic agent chloroquine, the energy depleter dinitrophenol, and also by low temperature, suggesting that recycling of the receptor is an energy- and temperature-dependent process. Data suggest that approximately 70-80% of internalized (125)I-ANP is processed through a lysosomal degradative pathway; however, 20-25% of internalized ligand is released intact into the cell exterior through an alternative mechanism involving an chloroquine-insensitive pathway. It is implied that internalization and processing of bound ANP-NPRA complexes may play an important role in mediating the biological action of hormone and the receptor protein. In retrospect, this could occur at the level of receptor regulation or through the initiation of ANP mediated signals. It is envisioned that the endocytotic pathway of ligand-receptor complexes of ANP-NPRA would lead to termination and/or diminished responsiveness of ANP in target cells.
我们利用稳定转染的、表达高密度受体的293细胞,研究了重组鸟苷酸环化酶/心钠素受体-A(NPRA)的内化、运输及下调的动力学过程。心房利钠肽(ANP)与NPRA结合后,配体-受体复合物被内化,在细胞内进行处理,并被隔离到亚细胞区室中,这为直接检测完整细胞中NPRA代谢转换的动力学提供了一种方法。配体-受体复合物从细胞表面向细胞内区室的转运似乎与ANP依赖的NPRA下调有关。通过对细胞表面受体进行胰蛋白酶消化,发现约40%-50%内化的配体-受体复合物以明显的t(1/2)=8分钟循环回到质膜。NPRA的循环被溶酶体促渗剂氯喹、能量耗尽剂二硝基苯酚以及低温所阻断,这表明受体的循环是一个能量和温度依赖的过程。数据表明,约70%-80%内化的(125)I-ANP通过溶酶体降解途径进行处理;然而,20%-25%内化的配体通过一种涉及对氯喹不敏感途径的替代机制完整地释放到细胞外。这意味着结合的ANP-NPRA复合物的内化和处理可能在介导激素和受体蛋白的生物学作用中起重要作用。回想起来,这可能发生在受体调节水平或通过启动ANP介导的信号。可以设想,ANP-NPRA配体-受体复合物的内吞途径将导致靶细胞中ANP的终止和/或反应性降低。